Rebecca L Greenberg

Primary role as department lead is to make certain teams are running smoothly, challenging them to bring innovation and creativity to all aspects of deliverables, ensure strategic alignment across all disciplines. Last but not least, she is also responsible for agency (organic and new business) and people growth.

• Oversaw the Gilead HIV HCP Franchise (four workstreams) Genentech’s Avastin and Stemline Therapeutics - Cultivate healthy client relationships - Mobilize and build internal teams; assign appropriate resources -Led the launches US HCP launch of Gilead’s Truvada for PrEP and BIKTARVY for HIV -Led the Global and US launch of Merck’s HCV brand, Zepatier

• Business Unit Lead for the East Coast office, responsible for building the East Coast division -Brand lead for the Novo Nordisk anti-obesity therapy, Saxenda, -Partner with the internal Strategy and Innovation Group to serve as consultants to the Field Force Technology team at Novo Nordisk to ensure successful digital selling implementation -Served as pitch account lead and to identify new and organic growth opportunities to expand Giant East

• Therapeutic Champion for the Merck Infectious Disease Franchise, ISENTRESS, Victrelis and PegIntron - Brand lead for Novartis Neuroendocrine Tumor brands Sandostatin and Afinitor -Strategic lead for Kalydeco, a breakthrough product for Cystic Fibrosis -Oversaw EXJADE US and Global for Iron Overload Due to Blood Transfusions -Partnered with Business Development as account lead for pitches and organic growth

• Global launch lead for OraQuick Hep C oral test -Global and US launch lead for Prezista, a protease inhibitor for HIV and Intelence, an NNRTI for HIV -US launch lead for BMS/Pfizer co-promote anticoagulant, ELIQUIS -Oversaw Extavia and Gilenya US launches for Novartis Multiple Sclerosis franchise and Bayer Diabetes Healthcare glucose meter franchise -Promoted several times during my tenure at the Bloc

• Launched and managed professional promotion activity of Biovail Pharmaceuticals, Inc
• Hypertension portfolio

• Oversaw all aspects of professional promotion for Pfizer Inc.'s Glucotrol XL, type 2 diabetes

• Relaunched Glucophage and prelaunch preparation of Glucophage XR for type 2 diabetes; DTC promotion for Accutane

• Hospital for For Special Surgery (Orthopedics)
• NY Weill Cornell Hospital (HIV)
• Naomi Berrie Diabetes Center (Diabetes), -Managed day-to-day operations, set policy and hired appropriate staff for a high-volume HIV specialist practice, orthopedic surgeon practice and a multi-specialty ambulatory diabetes care center